Physician profile
Marshall E Noel
NPI 1184718280
$4,415.96
in general payments reported to CMS, 2019-2025
23 companies · $303 in 2025
The $303 reported for 2025 was more than what 87% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $977 · 2020: $540 · 2021: $1,107 · 2022: $347 · 2023: $793 · 2024: $350 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,418 · Education: $27.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,418.07 |
| Education | $27.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,223.98 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $575.29 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $427.43 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $369.61 | 2019-2024 | |
| Therapeuticsmd, INC. | $300.23 | 2019-2022 | |
| Hologic Sales and Service, LLC | $232.06 | 2019-2024 | Aptima |
| Astellas Pharma US INC | $171.91 | 2019-2025 | Veozah |
| Exact Sciences Corporation | $164.55 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Novo Nordisk INC | $144.46 | 2023 | Wegovy |
| Myovant Sciences INC. | $130.20 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $122.49 | 2021-2023 | |
| Aspira Women'S Health INC | $116.44 | 2019 | |
| Amag Pharmaceuticals, INC. | $76.78 | 2019-2020 | |
| Coloplast Corp | $70.28 | 2019-2022 | |
| Millicent US INC | $59.45 | 2021-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $55.65 | 2023 | Prolia, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $47.04 | 2021-2023 | |
| Evofem Biosciences, INC. | $33.20 | 2020 | |
| Baxter Healthcare | $25.28 | 2024 | Perclot |
| Allergan, INC. | $24.96 | 2020 | |
| Ethicon US, LLC | $17.34 | 2025 | Stratafix, Surgicel Nu-Knit, Vistaseal |
| Organon LLC | $16.08 | 2021 | |
| Avion Pharmaceuticals | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Noel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.